Watchlist Price Alert

Impel Pharmaceuticals Inc... (IMPL)

NASDAQ: IMPL · Real-Time Price · USD

0.04

-0.01 (-27.27%)

At close: Dec 20, 2023, 8:58 PM

Impel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-106.31M	-76.54M	-45.8M	-41.86M
Depreciation & Amortization	1.2M	1.09M	1.08M	722K
Stock-Based Compensation	5.19M	3.13M	3.64M	794K
Other Working Capital	-887K	4.59M	38K	1.79M
Other Non-Cash Items	19.29M	1.61M	208K	642K
Deferred Income Tax	n/a	2.13M	153K	n/a
Change in Working Capital	-13.01M	2.21M	1.54M	3.21M
Operating Cash Flow	-93.64M	-66.36M	-39.18M	-36.49M
Capital Expenditures	-1.38M	-408K	-1.78M	-1.52M
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.38M	-408K	-1.78M	-1.52M
Debt Repayment	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	67.46M	147.89M	11.06M	21K
Financial Cash Flow	67.46M	147.89M	11.06M	21K
Net Cash Flow	-27.56M	81.12M	-29.91M	-37.99M
Free Cash Flow	-95.02M	-66.77M	-40.97M	-38.01M